Showing results (4331-4340 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|January 24, 2012
Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumorRobyn Macfarlane, Melanie Seal, Caroline Speers, et al.The Oncologist|January 31, 2012
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO)Isabelle Ray-Coquard, Antoine Italiano, Emmanuelle Bompas, et al.The Oncologist|April 6, 2012
Lapatinib for advanced or metastatic breast cancerFrans L Opdam, Henk-Jan Guchelaar, Jos H Beijnen, et al.The Oncologist|April 1, 2011
Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence?Yu-Ning Wong, Rebecca A Ottesen, Melissa E Hughes, et al.The Oncologist|April 16, 2011
The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the futureSamantha Pozzi, Noopur RajeThe Oncologist|June 30, 2011
Prognostic impact of phosphorylated HER-2 in HER-2+ primary breast cancerNaoki Hayashi, Takayuki Iwamoto, Ana M Gonzalez-Angulo, et al.The Oncologist|August 13, 2011
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic reviewConsuelo Buttigliero, Chiara Monagheddu, Paola Petroni, et al.The Oncologist|August 13, 2011
If I am in the mood, I enjoy it: an exploration of cancer-related fatigue and sexual functioning in women with breast cancerKate Webber, Kelly Mok, Barbara Bennett, et al.The Oncologist|August 3, 2011
An observational study of bevacizumab-induced hypertension as a clinical biomarker of antitumor activityOlivier Mir, Romain Coriat, Laure Cabanes, et al.The Oncologist|July 12, 2011
Cardiovascular toxicity profiles of vascular-disrupting agentsIshwaria M Subbiah, Daniel J Lenihan, Apostolia M TsimberidouPageof 571